nodes	percent_of_prediction	percent_of_DWPC	metapath
Fomepizole—ADH1B—esophageal cancer	0.619	0.805	CbGaD
Fomepizole—CYP2A6—esophageal cancer	0.15	0.195	CbGaD
Fomepizole—CAT—exocrine gland—esophageal cancer	0.00694	0.111	CbGeAlD
Fomepizole—CAT—neck—esophageal cancer	0.00444	0.0713	CbGeAlD
Fomepizole—ADH1C—bronchus—esophageal cancer	0.00379	0.0608	CbGeAlD
Fomepizole—ADH1A—trachea—esophageal cancer	0.00347	0.0557	CbGeAlD
Fomepizole—ADH1C—trachea—esophageal cancer	0.0034	0.0546	CbGeAlD
Fomepizole—CAT—epithelium—esophageal cancer	0.00302	0.0485	CbGeAlD
Fomepizole—ADH1A—digestive system—esophageal cancer	0.00298	0.0479	CbGeAlD
Fomepizole—CAT—bronchus—esophageal cancer	0.00297	0.0477	CbGeAlD
Fomepizole—CAT—smooth muscle tissue—esophageal cancer	0.00291	0.0467	CbGeAlD
Fomepizole—ADH1B—bronchus—esophageal cancer	0.00268	0.043	CbGeAlD
Fomepizole—CAT—trachea—esophageal cancer	0.00267	0.0429	CbGeAlD
Fomepizole—ADH1A—lung—esophageal cancer	0.00249	0.04	CbGeAlD
Fomepizole—ADH1C—lung—esophageal cancer	0.00244	0.0393	CbGeAlD
Fomepizole—ADH1B—trachea—esophageal cancer	0.0024	0.0386	CbGeAlD
Fomepizole—CAT—digestive system—esophageal cancer	0.0023	0.0369	CbGeAlD
Fomepizole—ADH1B—digestive system—esophageal cancer	0.00207	0.0332	CbGeAlD
Fomepizole—CAT—lung—esophageal cancer	0.00192	0.0308	CbGeAlD
Fomepizole—ADH1B—lung—esophageal cancer	0.00173	0.0277	CbGeAlD
Fomepizole—ADH1A—lymph node—esophageal cancer	0.0017	0.0274	CbGeAlD
Fomepizole—ADH1C—lymph node—esophageal cancer	0.00167	0.0268	CbGeAlD
Fomepizole—CAT—lymph node—esophageal cancer	0.00131	0.0211	CbGeAlD
Fomepizole—ADH1B—lymph node—esophageal cancer	0.00118	0.019	CbGeAlD
Fomepizole—CYP2A6—lung—esophageal cancer	0.000872	0.014	CbGeAlD
Fomepizole—CYP2E1—digestive system—esophageal cancer	0.000494	0.00793	CbGeAlD
Fomepizole—CYP2E1—lung—esophageal cancer	0.000412	0.00662	CbGeAlD
Fomepizole—Phlebitis—Carboplatin—esophageal cancer	0.000289	0.0999	CcSEcCtD
Fomepizole—Taste metallic—Methotrexate—esophageal cancer	0.000173	0.06	CcSEcCtD
Fomepizole—Anuria—Methotrexate—esophageal cancer	0.000158	0.0546	CcSEcCtD
Fomepizole—ADH1B—Metabolism—CA1—esophageal cancer	0.000132	0.000798	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—SLC10A2—esophageal cancer	0.000132	0.000798	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—MYC—esophageal cancer	0.000131	0.000787	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—SLC52A3—esophageal cancer	0.000129	0.000777	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—BLVRB—esophageal cancer	0.000129	0.000777	CbGpPWpGaD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000128	0.000773	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—SLC39A6—esophageal cancer	0.000127	0.000762	CbGpPWpGaD
Fomepizole—CYP2A6—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000123	0.000741	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CA2—esophageal cancer	0.000121	0.00073	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CA2—esophageal cancer	0.000121	0.00073	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—ADH7—esophageal cancer	0.000121	0.000727	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CA1—esophageal cancer	0.000119	0.000718	CbGpPWpGaD
Fomepizole—CAT—Metabolism—SLC10A2—esophageal cancer	0.000119	0.000718	CbGpPWpGaD
Fomepizole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000118	0.00071	CbGpPWpGaD
Fomepizole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000115	0.000693	CbGpPWpGaD
Fomepizole—CYP2A6—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000114	0.000684	CbGpPWpGaD
Fomepizole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000113	0.000679	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ADH7—esophageal cancer	0.000113	0.000678	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PLCE1—esophageal cancer	0.000113	0.000678	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PLCE1—esophageal cancer	0.000113	0.000678	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ADH7—esophageal cancer	0.000113	0.000678	CbGpPWpGaD
Fomepizole—CYP2E1—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000112	0.000677	CbGpPWpGaD
Fomepizole—CYP2E1—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000111	0.00067	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PIK3CA—esophageal cancer	0.000111	0.000668	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—SLC10A2—esophageal cancer	0.00011	0.000661	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—CA1—esophageal cancer	0.00011	0.000661	CbGpPWpGaD
Fomepizole—CYP2A6—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00011	0.000661	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CA2—esophageal cancer	0.000109	0.000657	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—CREBBP—esophageal cancer	0.000108	0.000653	CbGpPWpGaD
Fomepizole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000108	0.000651	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—RB1—esophageal cancer	0.000108	0.000651	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—TP53—esophageal cancer	0.000107	0.000646	CbGpPWpGaD
Fomepizole—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000107	0.000643	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—ADH7—esophageal cancer	0.000106	0.000637	CbGpPWpGaD
Fomepizole—CYP2E1—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000106	0.000637	CbGpPWpGaD
Fomepizole—Pain—Carboplatin—esophageal cancer	0.000105	0.0362	CcSEcCtD
Fomepizole—CAT—Metabolism—PLCE1—esophageal cancer	0.000101	0.000611	CbGpPWpGaD
Fomepizole—CAT—Metabolism—ADH7—esophageal cancer	0.000101	0.000611	CbGpPWpGaD
Fomepizole—Hiccups—Cisplatin—esophageal cancer	0.0001	0.0348	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CA2—esophageal cancer	0.0001	0.000605	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ADH1B—esophageal cancer	9.88e-05	0.000595	CbGpPWpGaD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	9.73e-05	0.000586	CbGpPWpGaD
Fomepizole—Body temperature increased—Carboplatin—esophageal cancer	9.66e-05	0.0334	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—CDKN2A—esophageal cancer	9.5e-05	0.000572	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—TYMP—esophageal cancer	9.44e-05	0.000568	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—TYMP—esophageal cancer	9.44e-05	0.000568	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ADH7—esophageal cancer	9.33e-05	0.000562	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PLCE1—esophageal cancer	9.33e-05	0.000562	CbGpPWpGaD
Fomepizole—CYP2A6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	9.33e-05	0.000562	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—ADH1B—esophageal cancer	9.28e-05	0.000559	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CYP26A1—esophageal cancer	9.18e-05	0.000553	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CYP26A1—esophageal cancer	9.18e-05	0.000553	CbGpPWpGaD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	9.15e-05	0.000551	CbGpPWpGaD
Fomepizole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	9.1e-05	0.000548	CbGpPWpGaD
Fomepizole—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	8.98e-05	0.00054	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ALOX15—esophageal cancer	8.95e-05	0.000539	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ALOX15—esophageal cancer	8.95e-05	0.000539	CbGpPWpGaD
Fomepizole—CAT—Metabolism—ADH1B—esophageal cancer	8.89e-05	0.000535	CbGpPWpGaD
Fomepizole—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	8.77e-05	0.000528	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—ABCC2—esophageal cancer	8.77e-05	0.000528	CbGpPWpGaD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	8.67e-05	0.000522	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—CYP26A1—esophageal cancer	8.63e-05	0.00052	CbGpPWpGaD
Fomepizole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	8.55e-05	0.000515	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GSTO1—esophageal cancer	8.54e-05	0.000514	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GSTO1—esophageal cancer	8.54e-05	0.000514	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—TPI1—esophageal cancer	8.54e-05	0.000514	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—TPI1—esophageal cancer	8.54e-05	0.000514	CbGpPWpGaD
Fomepizole—CAT—Metabolism—TYMP—esophageal cancer	8.5e-05	0.000512	CbGpPWpGaD
Fomepizole—Phlebitis—Cisplatin—esophageal cancer	8.47e-05	0.0293	CcSEcCtD
Fomepizole—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	8.44e-05	0.000508	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—ADH7—esophageal cancer	8.37e-05	0.000504	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CYP26A1—esophageal cancer	8.27e-05	0.000498	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ALDOB—esophageal cancer	8.19e-05	0.000493	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ADH1B—esophageal cancer	8.19e-05	0.000493	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ALDOB—esophageal cancer	8.19e-05	0.000493	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—NFE2L2—esophageal cancer	8.15e-05	0.000491	CbGpPWpGaD
Fomepizole—CAT—Metabolism—ALOX15—esophageal cancer	8.06e-05	0.000485	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—GSTO1—esophageal cancer	8.02e-05	0.000483	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GAPDH—esophageal cancer	7.88e-05	0.000474	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GAPDH—esophageal cancer	7.88e-05	0.000474	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—TYMP—esophageal cancer	7.82e-05	0.000471	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CRABP1—esophageal cancer	7.81e-05	0.00047	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CRABP1—esophageal cancer	7.81e-05	0.00047	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—CDKN1A—esophageal cancer	7.76e-05	0.000467	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GSTO1—esophageal cancer	7.69e-05	0.000463	CbGpPWpGaD
Fomepizole—CAT—Metabolism—TPI1—esophageal cancer	7.69e-05	0.000463	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—CYP26A1—esophageal cancer	7.61e-05	0.000458	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GNG7—esophageal cancer	7.43e-05	0.000447	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GNG7—esophageal cancer	7.43e-05	0.000447	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ALOX15—esophageal cancer	7.42e-05	0.000446	CbGpPWpGaD
Fomepizole—Hiccups—Capecitabine—esophageal cancer	7.41e-05	0.0256	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—EP300—esophageal cancer	7.39e-05	0.000445	CbGpPWpGaD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	7.37e-05	0.000444	CbGpPWpGaD
Fomepizole—CAT—Metabolism—ALDOB—esophageal cancer	7.37e-05	0.000444	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—ADH1B—esophageal cancer	7.34e-05	0.000442	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GAPDH—esophageal cancer	7.09e-05	0.000427	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—TPI1—esophageal cancer	7.07e-05	0.000426	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GSTO1—esophageal cancer	7.07e-05	0.000426	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CRABP1—esophageal cancer	7.03e-05	0.000423	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ALDH2—esophageal cancer	6.96e-05	0.000419	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ALDH2—esophageal cancer	6.96e-05	0.000419	CbGpPWpGaD
Fomepizole—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	6.93e-05	0.000417	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—CYP26A1—esophageal cancer	6.82e-05	0.000411	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ALDOB—esophageal cancer	6.78e-05	0.000408	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—CYP26A1—esophageal cancer	6.73e-05	0.000405	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GNG7—esophageal cancer	6.69e-05	0.000403	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—GSTT1—esophageal cancer	6.62e-05	0.000399	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—GSTT1—esophageal cancer	6.62e-05	0.000399	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CYP2A6—esophageal cancer	6.54e-05	0.000394	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CYP2A6—esophageal cancer	6.54e-05	0.000394	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—ALDH2—esophageal cancer	6.54e-05	0.000394	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GAPDH—esophageal cancer	6.53e-05	0.000393	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—CRABP1—esophageal cancer	6.47e-05	0.00039	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—GSTO1—esophageal cancer	6.34e-05	0.000382	CbGpPWpGaD
Fomepizole—CAT—Metabolism—ALDH2—esophageal cancer	6.27e-05	0.000377	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—GSTO1—esophageal cancer	6.25e-05	0.000376	CbGpPWpGaD
Fomepizole—Phlebitis—Capecitabine—esophageal cancer	6.24e-05	0.0216	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—GSTT1—esophageal cancer	6.22e-05	0.000375	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ENO1—esophageal cancer	6.2e-05	0.000373	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ENO1—esophageal cancer	6.2e-05	0.000373	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PTGS1—esophageal cancer	6.2e-05	0.000373	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PTGS1—esophageal cancer	6.2e-05	0.000373	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GNG7—esophageal cancer	6.15e-05	0.000371	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PSME1—esophageal cancer	6.11e-05	0.000368	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PSME2—esophageal cancer	6.11e-05	0.000368	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PSME2—esophageal cancer	6.11e-05	0.000368	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PSME1—esophageal cancer	6.11e-05	0.000368	CbGpPWpGaD
Fomepizole—CAT—Metabolism—GSTT1—esophageal cancer	5.96e-05	0.000359	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CYP2A6—esophageal cancer	5.89e-05	0.000355	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—PTGS1—esophageal cancer	5.83e-05	0.000351	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ALDH2—esophageal cancer	5.77e-05	0.000347	CbGpPWpGaD
Fomepizole—CAT—Metabolism—ENO1—esophageal cancer	5.59e-05	0.000336	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PTGS1—esophageal cancer	5.59e-05	0.000336	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PSME1—esophageal cancer	5.5e-05	0.000331	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PSME2—esophageal cancer	5.5e-05	0.000331	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—GSTT1—esophageal cancer	5.49e-05	0.00033	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—CYP2A6—esophageal cancer	5.42e-05	0.000326	CbGpPWpGaD
Fomepizole—CAT—Cellular responses to stress—TP53—esophageal cancer	5.29e-05	0.000318	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CYP1B1—esophageal cancer	5.27e-05	0.000318	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CYP1B1—esophageal cancer	5.27e-05	0.000318	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—ALDH2—esophageal cancer	5.17e-05	0.000311	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PTGS1—esophageal cancer	5.14e-05	0.000309	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ENO1—esophageal cancer	5.14e-05	0.000309	CbGpPWpGaD
Fomepizole—Bradycardia—Cisplatin—esophageal cancer	5.14e-05	0.0178	CcSEcCtD
Fomepizole—ADH1A—Metabolism—PSME1—esophageal cancer	5.06e-05	0.000305	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PSME2—esophageal cancer	5.06e-05	0.000305	CbGpPWpGaD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TP53—esophageal cancer	4.98e-05	0.0003	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CYP19A1—esophageal cancer	4.96e-05	0.000299	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CYP19A1—esophageal cancer	4.96e-05	0.000299	CbGpPWpGaD
Fomepizole—CYP2A6—Biological oxidations—CYP1B1—esophageal cancer	4.96e-05	0.000298	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—GSTT1—esophageal cancer	4.92e-05	0.000296	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—TGFBR2—esophageal cancer	4.92e-05	0.000296	CbGpPWpGaD
Fomepizole—Visual impairment—Cisplatin—esophageal cancer	4.86e-05	0.0168	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—CYP2A6—esophageal cancer	4.86e-05	0.000293	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—HMOX1—esophageal cancer	4.85e-05	0.000292	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CYP1B1—esophageal cancer	4.75e-05	0.000286	CbGpPWpGaD
Fomepizole—Flushing—Cisplatin—esophageal cancer	4.68e-05	0.0162	CcSEcCtD
Fomepizole—CYP2A6—Biological oxidations—CYP19A1—esophageal cancer	4.66e-05	0.000281	CbGpPWpGaD
Fomepizole—CYP2E1—Biological oxidations—PTGS1—esophageal cancer	4.61e-05	0.000277	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—HMOX1—esophageal cancer	4.53e-05	0.000272	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—HMOX1—esophageal cancer	4.53e-05	0.000272	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CYP19A1—esophageal cancer	4.46e-05	0.000269	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—CYP1B1—esophageal cancer	4.37e-05	0.000263	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ABCB1—esophageal cancer	4.34e-05	0.000262	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—ABCB1—esophageal cancer	4.34e-05	0.000262	CbGpPWpGaD
Fomepizole—Visual disturbance—Methotrexate—esophageal cancer	4.22e-05	0.0146	CcSEcCtD
Fomepizole—Vision blurred—Cisplatin—esophageal cancer	4.14e-05	0.0143	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CYP19A1—esophageal cancer	4.11e-05	0.000247	CbGpPWpGaD
Fomepizole—CAT—Metabolism—HMOX1—esophageal cancer	4.07e-05	0.000245	CbGpPWpGaD
Fomepizole—Anaemia—Cisplatin—esophageal cancer	4.06e-05	0.0141	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—CYP1B1—esophageal cancer	3.92e-05	0.000236	CbGpPWpGaD
Fomepizole—CAT—Metabolism—ABCB1—esophageal cancer	3.91e-05	0.000235	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—CYP1B1—esophageal cancer	3.86e-05	0.000233	CbGpPWpGaD
Fomepizole—Convulsion—Cisplatin—esophageal cancer	3.81e-05	0.0132	CcSEcCtD
Fomepizole—Bradycardia—Capecitabine—esophageal cancer	3.79e-05	0.0131	CcSEcCtD
Fomepizole—ADH1A—Metabolism—HMOX1—esophageal cancer	3.75e-05	0.000226	CbGpPWpGaD
Fomepizole—Anxiety—Cisplatin—esophageal cancer	3.73e-05	0.0129	CcSEcCtD
Fomepizole—Pharyngitis—Capecitabine—esophageal cancer	3.69e-05	0.0128	CcSEcCtD
Fomepizole—CYP2E1—Biological oxidations—CYP19A1—esophageal cancer	3.68e-05	0.000222	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—CYP19A1—esophageal cancer	3.63e-05	0.000219	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ABCB1—esophageal cancer	3.6e-05	0.000217	CbGpPWpGaD
Fomepizole—Visual impairment—Capecitabine—esophageal cancer	3.58e-05	0.0124	CcSEcCtD
Fomepizole—Tachycardia—Cisplatin—esophageal cancer	3.5e-05	0.0121	CcSEcCtD
Fomepizole—Flushing—Capecitabine—esophageal cancer	3.45e-05	0.0119	CcSEcCtD
Fomepizole—Eosinophilia—Methotrexate—esophageal cancer	3.43e-05	0.0119	CcSEcCtD
Fomepizole—Hypotension—Cisplatin—esophageal cancer	3.35e-05	0.0116	CcSEcCtD
Fomepizole—Dysgeusia—Capecitabine—esophageal cancer	3.17e-05	0.011	CcSEcCtD
Fomepizole—Back pain—Capecitabine—esophageal cancer	3.13e-05	0.0108	CcSEcCtD
Fomepizole—Decreased appetite—Cisplatin—esophageal cancer	3.12e-05	0.0108	CcSEcCtD
Fomepizole—Drowsiness—Methotrexate—esophageal cancer	3.08e-05	0.0107	CcSEcCtD
Fomepizole—Pain—Cisplatin—esophageal cancer	3.07e-05	0.0106	CcSEcCtD
Fomepizole—Vision blurred—Capecitabine—esophageal cancer	3.05e-05	0.0106	CcSEcCtD
Fomepizole—Anaemia—Capecitabine—esophageal cancer	2.99e-05	0.0104	CcSEcCtD
Fomepizole—Vertigo—Capecitabine—esophageal cancer	2.91e-05	0.0101	CcSEcCtD
Fomepizole—ADH1C—Metabolism—CREBBP—esophageal cancer	2.9e-05	0.000175	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CREBBP—esophageal cancer	2.9e-05	0.000175	CbGpPWpGaD
Fomepizole—Body temperature increased—Cisplatin—esophageal cancer	2.83e-05	0.00981	CcSEcCtD
Fomepizole—Pharyngitis—Methotrexate—esophageal cancer	2.75e-05	0.00951	CcSEcCtD
Fomepizole—Anxiety—Capecitabine—esophageal cancer	2.75e-05	0.00951	CcSEcCtD
Fomepizole—Visual impairment—Methotrexate—esophageal cancer	2.67e-05	0.00924	CcSEcCtD
Fomepizole—CAT—Metabolism—CREBBP—esophageal cancer	2.61e-05	0.000157	CbGpPWpGaD
Fomepizole—Shock—Capecitabine—esophageal cancer	2.6e-05	0.009	CcSEcCtD
Fomepizole—ADH1B—Metabolism—NOS3—esophageal cancer	2.6e-05	0.000156	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—NOS3—esophageal cancer	2.6e-05	0.000156	CbGpPWpGaD
Fomepizole—Tachycardia—Capecitabine—esophageal cancer	2.58e-05	0.00893	CcSEcCtD
Fomepizole—CYP2A6—Metabolism—SLC52A3—esophageal cancer	2.5e-05	0.000151	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—BLVRB—esophageal cancer	2.5e-05	0.000151	CbGpPWpGaD
Fomepizole—Hypotension—Capecitabine—esophageal cancer	2.47e-05	0.00855	CcSEcCtD
Fomepizole—Diarrhoea—Cisplatin—esophageal cancer	2.45e-05	0.00849	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CREBBP—esophageal cancer	2.41e-05	0.000145	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PTGS2—esophageal cancer	2.38e-05	0.000143	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PTGS2—esophageal cancer	2.38e-05	0.000143	CbGpPWpGaD
Fomepizole—Dysgeusia—Methotrexate—esophageal cancer	2.36e-05	0.00817	CcSEcCtD
Fomepizole—CAT—Metabolism—NOS3—esophageal cancer	2.34e-05	0.000141	CbGpPWpGaD
Fomepizole—Back pain—Methotrexate—esophageal cancer	2.33e-05	0.00807	CcSEcCtD
Fomepizole—Dyspepsia—Capecitabine—esophageal cancer	2.33e-05	0.00805	CcSEcCtD
Fomepizole—Decreased appetite—Capecitabine—esophageal cancer	2.3e-05	0.00795	CcSEcCtD
Fomepizole—Vomiting—Cisplatin—esophageal cancer	2.28e-05	0.00789	CcSEcCtD
Fomepizole—Vision blurred—Methotrexate—esophageal cancer	2.27e-05	0.00786	CcSEcCtD
Fomepizole—Rash—Cisplatin—esophageal cancer	2.26e-05	0.00782	CcSEcCtD
Fomepizole—Pain—Capecitabine—esophageal cancer	2.26e-05	0.00782	CcSEcCtD
Fomepizole—Dermatitis—Cisplatin—esophageal cancer	2.26e-05	0.00782	CcSEcCtD
Fomepizole—Anaemia—Methotrexate—esophageal cancer	2.23e-05	0.00771	CcSEcCtD
Fomepizole—Vertigo—Methotrexate—esophageal cancer	2.17e-05	0.0075	CcSEcCtD
Fomepizole—Gastrointestinal pain—Capecitabine—esophageal cancer	2.16e-05	0.00748	CcSEcCtD
Fomepizole—ADH1A—Metabolism—NOS3—esophageal cancer	2.15e-05	0.00013	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PTGS2—esophageal cancer	2.14e-05	0.000129	CbGpPWpGaD
Fomepizole—Nausea—Cisplatin—esophageal cancer	2.13e-05	0.00737	CcSEcCtD
Fomepizole—CYP2A6—Metabolism—SLC10A2—esophageal cancer	2.13e-05	0.000128	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CA1—esophageal cancer	2.13e-05	0.000128	CbGpPWpGaD
Fomepizole—Body temperature increased—Capecitabine—esophageal cancer	2.09e-05	0.00723	CcSEcCtD
Fomepizole—Abdominal pain—Capecitabine—esophageal cancer	2.09e-05	0.00723	CcSEcCtD
Fomepizole—Convulsion—Methotrexate—esophageal cancer	2.09e-05	0.00723	CcSEcCtD
Fomepizole—CYP2E1—Metabolism—BLVRB—esophageal cancer	1.98e-05	0.000119	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—SLC52A3—esophageal cancer	1.98e-05	0.000119	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—EP300—esophageal cancer	1.98e-05	0.000119	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—EP300—esophageal cancer	1.98e-05	0.000119	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PTGS2—esophageal cancer	1.97e-05	0.000119	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CA2—esophageal cancer	1.95e-05	0.000117	CbGpPWpGaD
Fomepizole—Hypotension—Methotrexate—esophageal cancer	1.84e-05	0.00636	CcSEcCtD
Fomepizole—CYP2A6—Metabolism—ADH7—esophageal cancer	1.81e-05	0.000109	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PLCE1—esophageal cancer	1.81e-05	0.000109	CbGpPWpGaD
Fomepizole—Diarrhoea—Capecitabine—esophageal cancer	1.81e-05	0.00626	CcSEcCtD
Fomepizole—CAT—Metabolism—EP300—esophageal cancer	1.78e-05	0.000107	CbGpPWpGaD
Fomepizole—Somnolence—Methotrexate—esophageal cancer	1.75e-05	0.00605	CcSEcCtD
Fomepizole—Dizziness—Capecitabine—esophageal cancer	1.75e-05	0.00605	CcSEcCtD
Fomepizole—Dyspepsia—Methotrexate—esophageal cancer	1.73e-05	0.00599	CcSEcCtD
Fomepizole—Decreased appetite—Methotrexate—esophageal cancer	1.71e-05	0.00592	CcSEcCtD
Fomepizole—CYP2E1—Metabolism—SLC10A2—esophageal cancer	1.68e-05	0.000101	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CA1—esophageal cancer	1.68e-05	0.000101	CbGpPWpGaD
Fomepizole—Pain—Methotrexate—esophageal cancer	1.68e-05	0.00582	CcSEcCtD
Fomepizole—Vomiting—Capecitabine—esophageal cancer	1.68e-05	0.00582	CcSEcCtD
Fomepizole—Rash—Capecitabine—esophageal cancer	1.67e-05	0.00577	CcSEcCtD
Fomepizole—Dermatitis—Capecitabine—esophageal cancer	1.66e-05	0.00576	CcSEcCtD
Fomepizole—Headache—Capecitabine—esophageal cancer	1.66e-05	0.00573	CcSEcCtD
Fomepizole—ADH1A—Metabolism—EP300—esophageal cancer	1.64e-05	9.86e-05	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Methotrexate—esophageal cancer	1.61e-05	0.00557	CcSEcCtD
Fomepizole—CYP2A6—Metabolism—ADH1B—esophageal cancer	1.59e-05	9.56e-05	CbGpPWpGaD
Fomepizole—Nausea—Capecitabine—esophageal cancer	1.57e-05	0.00543	CcSEcCtD
Fomepizole—Body temperature increased—Methotrexate—esophageal cancer	1.56e-05	0.00538	CcSEcCtD
Fomepizole—Abdominal pain—Methotrexate—esophageal cancer	1.56e-05	0.00538	CcSEcCtD
Fomepizole—CYP2E1—Metabolism—CA2—esophageal cancer	1.54e-05	9.26e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—TYMP—esophageal cancer	1.52e-05	9.13e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CYP26A1—esophageal cancer	1.48e-05	8.88e-05	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PIK3CA—esophageal cancer	1.46e-05	8.81e-05	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PIK3CA—esophageal cancer	1.46e-05	8.81e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ALOX15—esophageal cancer	1.44e-05	8.66e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ADH7—esophageal cancer	1.43e-05	8.61e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PLCE1—esophageal cancer	1.43e-05	8.61e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTO1—esophageal cancer	1.37e-05	8.26e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—TPI1—esophageal cancer	1.37e-05	8.26e-05	CbGpPWpGaD
Fomepizole—Diarrhoea—Methotrexate—esophageal cancer	1.35e-05	0.00466	CcSEcCtD
Fomepizole—CAT—Metabolism—PIK3CA—esophageal cancer	1.32e-05	7.93e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ALDOB—esophageal cancer	1.32e-05	7.92e-05	CbGpPWpGaD
Fomepizole—Dizziness—Methotrexate—esophageal cancer	1.3e-05	0.0045	CcSEcCtD
Fomepizole—CYP2A6—Metabolism—GAPDH—esophageal cancer	1.27e-05	7.62e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CRABP1—esophageal cancer	1.25e-05	7.55e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ADH1B—esophageal cancer	1.25e-05	7.55e-05	CbGpPWpGaD
Fomepizole—Vomiting—Methotrexate—esophageal cancer	1.25e-05	0.00433	CcSEcCtD
Fomepizole—Rash—Methotrexate—esophageal cancer	1.24e-05	0.00429	CcSEcCtD
Fomepizole—Dermatitis—Methotrexate—esophageal cancer	1.24e-05	0.00429	CcSEcCtD
Fomepizole—Headache—Methotrexate—esophageal cancer	1.23e-05	0.00427	CcSEcCtD
Fomepizole—ADH1A—Metabolism—PIK3CA—esophageal cancer	1.21e-05	7.3e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—TYMP—esophageal cancer	1.2e-05	7.22e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GNG7—esophageal cancer	1.19e-05	7.19e-05	CbGpPWpGaD
Fomepizole—Nausea—Methotrexate—esophageal cancer	1.17e-05	0.00404	CcSEcCtD
Fomepizole—CYP2E1—Metabolism—CYP26A1—esophageal cancer	1.17e-05	7.02e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ALOX15—esophageal cancer	1.14e-05	6.84e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ALDH2—esophageal cancer	1.12e-05	6.73e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—TPI1—esophageal cancer	1.08e-05	6.53e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTO1—esophageal cancer	1.08e-05	6.53e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—GSTT1—esophageal cancer	1.06e-05	6.4e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ALDOB—esophageal cancer	1.04e-05	6.26e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GAPDH—esophageal cancer	1e-05	6.02e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PTGS1—esophageal cancer	9.97e-06	6e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ENO1—esophageal cancer	9.97e-06	6e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CRABP1—esophageal cancer	9.92e-06	5.97e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PSME2—esophageal cancer	9.82e-06	5.91e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PSME1—esophageal cancer	9.82e-06	5.91e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GNG7—esophageal cancer	9.43e-06	5.68e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ALDH2—esophageal cancer	8.84e-06	5.32e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CYP1B1—esophageal cancer	8.48e-06	5.1e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—GSTT1—esophageal cancer	8.41e-06	5.06e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CYP2A6—esophageal cancer	8.31e-06	5e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CYP19A1—esophageal cancer	7.97e-06	4.8e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PTGS1—esophageal cancer	7.88e-06	4.74e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ENO1—esophageal cancer	7.88e-06	4.74e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PSME2—esophageal cancer	7.76e-06	4.67e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PSME1—esophageal cancer	7.76e-06	4.67e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—HMOX1—esophageal cancer	7.27e-06	4.38e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ABCB1—esophageal cancer	6.98e-06	4.2e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CYP1B1—esophageal cancer	6.7e-06	4.03e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CYP19A1—esophageal cancer	6.3e-06	3.79e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—HMOX1—esophageal cancer	5.75e-06	3.46e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ABCB1—esophageal cancer	5.52e-06	3.32e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CREBBP—esophageal cancer	4.66e-06	2.81e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—NOS3—esophageal cancer	4.18e-06	2.51e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PTGS2—esophageal cancer	3.82e-06	2.3e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CREBBP—esophageal cancer	3.69e-06	2.22e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—NOS3—esophageal cancer	3.3e-06	1.99e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—EP300—esophageal cancer	3.18e-06	1.91e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PTGS2—esophageal cancer	3.02e-06	1.82e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—EP300—esophageal cancer	2.51e-06	1.51e-05	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PIK3CA—esophageal cancer	2.35e-06	1.41e-05	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PIK3CA—esophageal cancer	1.86e-06	1.12e-05	CbGpPWpGaD
